Specific bacterial co-abundance groups are associated with inflammatory status in patients with ulcerative colitis

While there is increasing interest in microbiome-directed therapies for patients with ulcerative colitis (UC), the identification of microbial targets remains elusive, underlining the need for novel approaches.